Cardinal Health Inc (CAH)
Official siteHEALTHCARE • MEDICAL DISTRIBUTION • NYSE
Market Cap: $64.97B
Last updated: Nov 17, 2026 at 11:05 AM ET
Cardinal Health Inc (CAH) Financials: Revenue, Profit and Cash Flow
Cardinal Health reported revenue of $254.25B for the fiscal year ended Jun 30, 2026, up 14.2% from the year before. That year, net income was $1.71B with a net margin of 0.7%, operating cash flow was $5.17B and free cash flow was $4.53B. The quarter ended Sep 30, 2026 had revenue of $67.51B and net income of $556.00M.
Revenue and Margins
The operating margin was 1.0% in the fiscal year ended Jun 2026. Over the 9 years to Jun 2026, revenue grew from $129.98B, a compound annual rate of 7.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $254.25B | +14.2% | 3.8% | 1.0% | 0.7% |
| Jun 2025 | $222.58B | -1.9% | 3.7% | 1.0% | 0.7% |
| Jun 2024 | $226.83B | +10.7% | 3.3% | 0.5% | 0.4% |
| Jun 2023 | $204.98B | +13.0% | 3.4% | 0.4% | 0.2% |
| Jun 2022 | $181.33B | +11.6% | 3.6% | -0.3% | -0.5% |
| Jun 2021 | $162.47B | +6.2% | 4.2% | 0.3% | 0.4% |
| Jun 2020 | $152.92B | +5.1% | 4.5% | -2.7% | -2.4% |
| Jun 2019 | $145.53B | +6.4% | 4.7% | 1.4% | 0.9% |
| Jun 2018 | $136.81B | +5.3% | 5.2% | 0.1% | 0.2% |
| Jun 2017 | $129.98B | N/A | 5.0% | 1.6% | 1.0% |
Income Statement
In the fiscal year ended Jun 2026, net income rose 8.9% from the year before. In the quarter ended Sep 2026, net income rose 22.5% from the same quarter a year earlier.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B |
| Cost of revenue | $244.47B | $214.41B | $219.41B | $198.10B | $174.84B | $155.69B | $146.05B | $138.70B | $129.63B | $123.43B |
| Gross profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B | $6.78B | $6.87B | $6.83B | $7.18B | $6.54B |
| Operating income | $2.61B | $2.27B | $1.24B | $752.00M | -$607.00M | $472.00M | -$4.10B | $2.06B | $126.00M | $2.12B |
| Net income | $1.71B | $1.57B | $853.00M | $331.00M | -$937.00M | $612.00M | -$3.69B | $1.36B | $259.00M | $1.29B |
| EBITDA | $3.60B | $3.11B | $1.96B | $1.44B | $63.00M | $1.30B | -$3.18B | $3.04B | $1.14B | $2.84B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67.51B | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B | $54.88B | $55.26B | $52.28B | $59.87B | $54.87B | $57.44B |
| Gross profit | $2.60B | $2.56B | $2.50B | $2.40B | $2.32B | $2.20B | $2.12B | $1.94B | $1.90B | $1.88B | $1.94B | $1.85B |
| Operating income | $753.00M | $729.00M | $509.00M | $707.00M | $668.00M | $428.00M | $730.00M | $549.00M | $568.00M | $401.00M | $369.00M | $505.00M |
| Net income | $556.00M | $400.00M | $380.00M | $471.00M | $454.00M | $243.00M | $508.00M | $401.00M | $417.00M | $233.00M | $262.00M | $369.00M |
Balance Sheet
As of Jun 2026, total debt of $8.89B exceeded cash and equivalents by $4.03B. Shareholder equity was negative, at -$2.88B, as total liabilities of $60.02B exceeded total assets of $57.30B.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B |
| Current assets | $38.75B | $36.37B | $34.88B | $33.74B | $32.94B | $31.05B | $25.94B | $25.75B | $24.55B | $28.34B |
| Cash and equivalents | $4.86B | $3.87B | $5.13B | $4.08B | $4.72B | $3.41B | $2.77B | $2.53B | $1.76B | $6.88B |
| Total liabilities | $60.02B | $55.76B | $48.33B | $46.31B | $44.58B | $42.66B | $38.97B | $34.63B | $33.88B | $33.17B |
| Short-term debt | $1.88B | $550.00M | $434.00M | $792.00M | $580.00M | $871.00M | $10.00M | $452.00M | $1.00B | $1.33B |
| Long-term debt | $7.00B | $7.98B | $4.66B | $3.91B | $4.74B | $5.37B | $6.76B | $7.58B | $8.01B | $9.07B |
| Shareholder equity | -$2.88B | -$2.78B | -$3.21B | -$2.96B | -$709.00M | $1.79B | $1.79B | $6.33B | $6.06B | $6.81B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $59.54B | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B |
| Total liabilities | $62.41B | $60.02B | $59.36B | $60.78B | $57.96B | $55.76B | $51.77B | $49.92B | $46.34B | $48.33B | $49.14B | $50.02B |
| Cash and equivalents | $5.26B | $4.86B | $3.94B | $2.78B | $4.59B | $3.87B | $3.33B | $3.81B | $2.87B | $5.13B | $3.72B | $4.59B |
| Shareholder equity | -$3.02B | -$2.88B | -$2.83B | -$2.88B | -$2.88B | -$2.78B | -$2.95B | -$2.99B | -$3.28B | -$3.21B | -$3.27B | -$3.45B |
Cash Flow
In the fiscal year ended Jun 2026, free cash flow was 87.6% of operating cash flow. Dividends and share repurchases together came to 41.1% of it.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.17B | $2.40B | $3.76B | $2.84B | $3.17B | $2.43B | $1.96B | $2.72B | $2.77B | $1.18B |
| Capital expenditures | $649.00M | $547.00M | $511.00M | $481.00M | $387.00M | $400.00M | $375.00M | $328.00M | $384.00M | $387.00M |
| Free cash flow | $4.53B | $1.85B | $3.25B | $2.36B | $2.79B | $2.03B | $1.58B | $2.39B | $2.38B | $797.00M |
| Dividends paid | $502.00M | $506.00M | $499.00M | $528.00M | $559.00M | $573.00M | $569.00M | $577.00M | $581.00M | $577.00M |
| Share repurchases | $1.36B | $765.00M | $750.00M | $2.00B | $1.00B | $200.00M | $350.00M | $600.00M | $550.00M | $600.00M |
| Investing cash flow | -$2.58B | -$5.59B | -$1.85B | -$454.00M | $567.00M | -$378.00M | $493.00M | $338.00M | -$5.61B | -$405.00M |
| Financing cash flow | -$1.60B | $1.94B | -$847.00M | -$3.05B | -$2.46B | -$1.32B | -$2.20B | -$2.29B | -$2.28B | $3.75B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.40B | $1.69B | $1.82B | $686.00M | $973.00M | $1.52B | $2.92B | -$396.00M | -$1.65B | $2.08B | -$27.00M | $1.18B |
| Capital expenditures | $157.00M | $264.00M | $146.00M | $131.00M | $108.00M | $232.00M | $126.00M | $99.00M | $90.00M | $193.00M | $112.00M | $114.00M |
| Free cash flow | $1.24B | $1.43B | $1.68B | $555.00M | $865.00M | $1.29B | $2.79B | -$495.00M | -$1.74B | $1.89B | -$139.00M | $1.06B |
Frequently Asked Questions About CAH
What is Cardinal Health's annual revenue?
Cardinal Health reported revenue of $254.25B for the fiscal year ended Jun 30, 2026.
How fast is Cardinal Health's revenue growing?
Revenue was up 14.2% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 7.4%.
Is Cardinal Health profitable?
Yes. Cardinal Health reported net income of $1.71B for the fiscal year ended Jun 30, 2026, with a net margin of 0.7%.
How much free cash flow does CAH generate?
For the fiscal year ended Jun 30, 2026, operating cash flow of $5.17B minus capital expenditures of $649.00M produced free cash flow of $4.53B.
How much debt does Cardinal Health have?
The balance sheet dated Jun 30, 2026 reported long-term debt of $7.00B, short-term debt of $1.88B and cash and equivalents of $4.86B.
CAH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts